PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-23

Date Title Company
23-May-2020 New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks EMD Serono